27 October 2022
Rajabboy Ahmadzoda, the head of the Sughd Province of Tajikistan, and Grigory Demidov, the head of international projects in Russia’s Pharmasynthesis company, discussed the implementation of a project to establish drug production in the region, as the press service of the head of the region reports.
“The parties discussed issues of enhancing cooperation in the pharmaceutical sector and the implementation of a new project for the construction of a pharmaceutical production plant,” the message reads.
According to Demidov, Pharmasynthesis is ready to cooperate with colleagues from Sughd Province. The company plans to supply pharmaceutical products to Tajikistan at low prices.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024